Generic drugs account for more than 90 percent of prescriptions filled in the United States. Recent studies have found concering variability in quality and safety America’s generic drug supply, most ...

The pharmaceutical executive Martin Shkreli made headlines this summer when he raised the price of a generic drug by over 5,000 percent. Led by Clay Wiske MD ’16, a team of researchers presented ...

Zydus won final FDA approval to market a generic version of Vumerity for adults with relapsing forms of MS and active SPMS.

They have the same active ingredients—but experts say there are some key factors that set these medications apart at the pharmacy counter. One of the biggest is cost. An employee inspects medications ...

According to the American Medical Association, health related costs have been on the rise in recent years. Overall, health-related spending in the U.S. increased by over 7% between 2022 and 2023, a ...

In a move that could eventually make weight loss drugs cheaper and easier to access, the Food and Drug Administration Monday approved a second generic in the category of medications known as GLP-1s.

A new investigative report released by Senators Kirsten Gillibrand (D-NY) and Rick Scott (R-FL), ranking member and chairman of the US Senate Special Committee on Aging, respectively, details the ...

COLUMBUS, Ohio – Generic drugs manufactured in India are linked to significantly more “severe adverse events” for patients who use them than equivalent drugs produced in the United States, a new study ...

About 120 drugs have lost or will lose patent protection in 2013. EvaluatePharma estimates that this accounts for nearly $29 billion in total annual revenue, a number which will grow ten-fold between ...

The Trump administration isn't planning to impose tariffs on generic drug imports, The Wall Street Journal reported, although the move isn't final and could change in the coming weeks. "The ...

WASHINGTON -- Federal officials have approved another generic version of the abortion pill mifepristone, a regulatory formality that quickly triggered pushback from anti-abortion groups and ...